Ultralife Corporation reported a challenging second quarter in 2025, with total revenue increasing by 13.0% to $48.6 million due to the Electrochem acquisition. However, GAAP EPS decreased significantly to $0.05 from $0.18 in the prior year, and operating income fell to $2.3 million from $3.9 million, primarily due to a 57.2% decline in Communications Systems sales and pressures on gross profit from product mix, tariffs, and freight costs.
Total revenue increased by 13.0% to $48.6 million, primarily driven by the inclusion of Electrochem Solutions, Inc.
GAAP EPS decreased to $0.05, down from $0.18 in the second quarter of 2024, reflecting a challenging period.
Communications Systems sales significantly declined by 57.2% to $2.7 million due to delayed purchase orders.
Gross profit remained flat at $11.6 million, but gross margin decreased to 23.9% from 26.9% due to product mix, higher tariffs, and freight costs.
Ultralife expects improved results in the second half of 2025 and into 2026, driven by a rebound in the Communications Systems business, new product programs for batteries, and sustained growth in global defense spending.
Visualization of income flow from segment revenue to net income